|
|
| (47 intermediate revisions by 7 users not shown) |
| Line 1: |
Line 1: |
| {{SI}} | | __NOTOC__ |
| {{WikiDoc Cardiology Network Infobox}} | | {{Cardiac disease in pregnancy}} |
| {{CMG}} | | {{CMG}}; {{AOEIC}} {{CZ}}; {{AC}}; {{LG}} |
|
| |
|
| '''Associate Editor-In-Chief:''' {{CZ}}
| | ==[[Cardiac disease in pregnancy overview|Overview]]== |
|
| |
|
| {{Editor Help}}
| | ==[[Cardiac disease in pregnancy pathophysiology|Pathophysiology]]== |
|
| |
|
| ==Definitions== | | ==[[Cardiac disease in pregnancy epidemiology and demographics|Epidemiology and Demographics]]== |
|
| |
|
| *[[Heart failure]] within last month of pregnancy or five months postpartum
| | ==[[Cardiac disease in pregnancy risk factors|Risk Factors]]== |
| *Absence of prior heart disease
| |
| *No determinable cause
| |
| *Strict echocardiographic indication of left ventricular dysfunction:
| |
| :*[[Ejection fraction]] <45% and/or
| |
| :*Fractional shortening <30%
| |
| :*End-diastolic dimension >2.7 cm/m2 BSA (body surface area)
| |
|
| |
|
| == Epidemiology and Demographics == | | ==Diagnosis== |
| | [[Cardiac disease in pregnancy history and symptoms|History and Symptoms]] | [[Cardiac disease in pregnancy physical examination|Physical Examination]] | [[Cardiac disease in pregnancy electrocardiogram|Electrocardiogram]] | [[Cardiac disease in pregnancy exercise testing|Exercise Testing]] | [[Cardiac disease in pregnancy radiation exposure|Radiation Exposure]] | [[Cardiac disease in pregnancy chest x ray|Chest X Ray]] | [[Cardiac disease in pregnancy echocardiography|Echocardiography]] | [[Cardiac disease in pregnancy MRI|MRI]] | [[Cardiac disease in pregnancy CT|CT]] | [[Cardiac disease in pregnancy catheterization#Pulmonary artery catheterization|Pulmonary artery catheterization]] | [[Cardiac disease in pregnancy catheterization#Cardiac catheterization|Cardiac catheterization]] | [[Cardiac disease in pregnancy cardiac ablation|Cardiac Ablation]] |
|
| |
|
| * Cardiovascular disease complicates 1- 4% of all pregnancies
| | ==Treatment== |
| * Together with DVT/PE has surpassed hemorrhage, infection, and hypertensive disorders as leading cause of maternal mortality (20-30%)
| | [[Cardiac disease in pregnancy and drug therapy|Cardiovascular Drug Therapy During Pregnancy]] | [[Cardiac disease in pregnancy labor and delivery|Labor and delivery]] | [[Cardiac disease in pregnancy resuscitation strategies|Resuscitation in Late Pregnancy]] |
| * Increasing numbers of women with [[congenital heart disease]] are now reaching childbearing age
| |
|
| |
|
| ==Physiology of Labor and Delivery== | | ==Prevention== |
| | [[Cardiac disease in pregnancy contraindications to pregnancy|Contraindications to pregnancy]] |
|
| |
|
| # Hemodynamics are altered substantially during labor and delivery secondary to [[anxiety]], [[pain]], and uterine contractions. Oxygen consumption increases threefold, and cardiac output rises progressively during labor owing to increases in both stroke volume and heart rate. Blood pressure is higher in the lateral position. Both the systolic and diastolic blood pressure increase markedly during contractions with a greater augmentation during the second stage. The form of anesthesia impacts the blood pressure. <br>
| | ==Cardiac Conditions Associated with Complications== |
| # By the time of delivery the [[Cardiac output]] (CO) has increased by 50%, the plasma volume has increased by 40% and the red cell mass has increased by 25 to 30%. <br>
| | ===I. Pre-existing Cardiac Disease=== |
| # The work of labor may increase the CO by 60% over the baseline level. <br>
| | =====[[Cardiac disease in pregnancy and congenital heart disease|Congenital Heart Disease]]===== |
| # During the second stage of labor the patient is on her back there is venous stasis, heart rate increases to > 120/min and the BP may be > 150 mm Hg. <br>
| |
| # Immediately following delivery, the uterus contracts and delivers a sudden bolus of 500-750 cc of blood to the circulatory system which may result in pulmonary edema in the patient with heart disease.
| |
|
| |
|
| ===Hemodynamic effect of cesarean section:=== | | =====[[Cardiac disease in pregnancy and repaired congenital heart disease|Repaired Congenital Heart Disease]]===== |
| To avoid the hemodynamic changes assocaited with vaginal delivery, cesarean section is frequently recommended for women with cardiovascular disease. This form of delivery can also be associated with hemodynamic fluctuations related to intubation, analgesic as well as anesthetic use. There can be a greater extent of blood loss as well as relief of caval compression.
| |
|
| |
|
| ===Hemodynamic changes postpartum:=== | | =====[[Cardiac disease in pregnancy and pulmonary hypertension|Pulmonary Hypertension]]===== |
| There can be a temporary increase in venous return immediately after delivery due to relief of caval compression in addition to blood shifting from the contracting uterus into the systemic circulation. This change and effective blood volume occurs despite blood loss during delivery and can result in a substantial rise in ventricular filling pressures, stroke volume, and CO that may lead to clinical deterioration.
| |
|
| |
|
| Both heart rate and CO returned to prelabor values by one hour after delivery and the blood pressure and stroke volume at 24 hours after delivery.
| | =====[[Cardiac disease in pregnancy and rheumatic heart disease|Rheumatic Heart Disease]]===== |
|
| |
|
| Hemodynamic adaptation of pregnancy persists postpartum and gradually returns to prepregnancy values within 12-24 weeks after delivery.
| | =====[[Cardiac disease in pregnancy and connective tissue disorders|Connective Tissue Disorders]]===== |
|
| |
|
| ===Effect of Pregnancy on Maternal Physiology=== | | ===II. Valvular Heart Disease=== |
|
| |
|
| # Corpus Luteum Produces Progesterone <br>
| | =====[[Cardiac disease in pregnancy and valvular heart disease#Mitral Stenosis|Mitral Stenosis]]===== |
| #* increased progesterone -> decreased smooth muscle tone -> therefore decreased SVR <br>
| |
| #* later in pregnancy the placenta produces progesterone <br> <br>
| |
| # Increased Estrogen Levels <br>
| |
| #* may increase contractility of heart <br> <br>
| |
| # Increased Renin and Aldosterone Levels Caused by Increased Estrogen <br>
| |
| #* enhances Na and water retention <br>
| |
| #* compensates for the decreased SVR <br>
| |
| #* by the middle trimester, plasma volume is increased by 40 to 45%. <br>
| |
| #* hemodilution -> anemia, but total red cell mass is not decreased. Rate of rise in volume is more rapid than rate of rise in red cell mass. This occurs until week 30 and is referred to as the physiologic anemia of pregnancy. The hematocrit can be as low as 33% to 38%. <br>
| |
| #* starts as early as 6 weeks <br>
| |
| #* greater increase in blood volume among multigravidas <br> <br>
| |
| # Cardiac Output Increases by 50% <br>
| |
| #* have a higher volume of more dilute blood to circulate <br>
| |
| #* need well oxygenated blood to circulate to the fetus <br>
| |
| #* begins to rise at 5<sup>th</sup> week, and cardiac output increases until week 24 at which time it plateaus <br>
| |
| #* resting pulse rate increases by 10 to 15 beats per minute. Pregnancy with multiple fetuses is associated with even more rapid heart rates. <br>
| |
| #* BP remains relatively unchanged when measured in the left lateral recumbent position <br>
| |
| #* hemodynamics measured in the supine position are erroneous because the uterus compresses the IVC decreasing the return from the lower extremities. Therefore may have syncope when a gravid stands up from a supine position. <br>
| |
| #* keep in mind that much of the blood is shunted to the placenta where it may pass from arterioles to venules bypassing the capillaries. May precipitate high cardiac output failure in some women. <br>
| |
| #* cardiac output increases in the lateral position and declines in the supine position owing to caval compression by the gravid uterus. <br>
| |
| #* the increase in CO in early pregnancy is due to an increase in stroke volume early on, but in the third trimester it is due to an increase in heart rate. <br> <br>
| |
| # Increased Respiratory Rate <br>
| |
| #* secondary to increased abdominal pressure, elevation of the diaphragm <br>
| |
| #* lowers carbon dioxide tension <br> <br>
| |
| # Blood Pressure <br>
| |
| #* arterial pressure begins to fall during the first trimester reaches a nadir in mid pregnancy and returns toward pregestational levels before term.
| |
| #* because diastolic blood pressure decreases substantially more than systolic blood pressure, the pulse pressure widens. <br>
| |
| #* reduction blood pressure is caused by a decline in systemic vascular resistance due to reduce vascular tone. This is mediated by gestational hormone activity, increased circulate levels of prostaglandins and atrial natriuretic peptides, as well as endothelial nitric oxide. Increased heat production by the developing fetus small and the creation of a lower resistance circulation in the uterus also play a role. <br> | |
| #* supine hypotensive syndrome of pregnancy: occurs in 11% of women. Associated with [[weakness]], [[lightheadedness]], [[nausea]], [[dizziness]] and even [[syncope]]. This is often explained by acute occlusion of the [[inferior vena cava]] by the enlarged uterus. Symptoms usually subside when the supine position is abandoned. <br> <br>
| |
| # Gastrointestinal changes
| |
| #* Gastric emptying is slower – in pregnancy women have reduced gastrointestinal motility.
| |
| #* An incompetent gastro-oesophageal sphincter leads to gastro-oesophageal reflux with greater danger of aspiration of gastric contents into the trachea.
| |
| #* Increased intragastric pressure in late pregnancy<ref>Jevon P, Raby M. Physiological and anatomical changes in pregnancy relevant to resuscitation. In: O'Donnell E, Pooni JS, editors. Resuscitation in Pregnancy. A practical approach. Oxford: Reed Educational and Professional Publishing Ltd.; 2001. p. 10-16.</ref>
| |
| # Other changes in pregnancy
| |
| #* Flared ribs
| |
| #* Breast hypertropy<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref> (may impede effective resuscitation)
| |
|
| |
|
| ==Fetal Physiology== | | =====[[Cardiac disease in pregnancy and valvular heart disease#Mitral Regurgitation|Mitral Regurgitation]]===== |
|
| |
|
| # Uterine blood flow increases by a factor of 50 during pregnancy <br>
| | =====[[Cardiac disease in pregnancy and valvular heart disease#Aortic Insufficiency|Aortic Insufficiency]]===== |
| # The uterine blood vessels remain dilated throughout pregnancy <br>
| |
| # Transfer of O2 across the placenta is flow-limited. <br>
| |
| # Fetal O2 tension is normally quite low (30 to 40 mmHg) <br>
| |
| # Supplemental O2 to the mother is quite effective in increasing fetal O2, particularly with fetal distress. <br>
| |
| # Normal fetal pH is 7.35. Fetal scalp pHs< 7.25 are abnormal. <br>
| |
| # Labor can precipitate fetal distress because during uterine contractions, uterine blood flow is nearly occluded. <br>
| |
| # In a mother with cyanosis, it is easier for problems to arise during labor because of the reduced reserve in O2 delivery. <br>
| |
| # With contractions, there may normally be a reduction or deceleration in the fetal heart rate, but this rapidly returns to normal. <br>
| |
| # In fetal distress, the decelerations are later in the contraction and persist, i.e. late decelerations. <br>
| |
| # Fetuses do not die suddenly during labor, and there are many minutes or hours of fetal distress before death so that there is time to intervene. <br>
| |
| # Placing the mother in the left lateral recumbent position and O2 will relieve many cases of fetal distress. <br>
| |
| # Fetal monitoring should be used in the presence of maternal heart disease, cardiac surgery, cardioversion. <br> <br>
| |
|
| |
|
| == History and Symptoms == | | =====[[Cardiac disease in pregnancy and valvular heart disease#Aortic Stenosis|Aortic Stenosis]]===== |
|
| |
|
| Often accompanied by symptoms of fatigue, decreased exercise capacity, hyperventilation, dyspnea, palpitations, lightheadedness, and even syncope. Leg edema is often observed late in pregnancy and can lead to an erroneous diagnosis of heart failure. The arterial pulsese are full and collapsing and are similar to those palpated in patiends with aortic insufficiency or hyperthyroidism.
| | =====[[Cardiac disease in pregnancy and valvular heart disease#Mechanical Prosthetic Valves|Mechanical Prosthetic Valves]]===== |
|
| |
|
| == Physical Examination == | | =====[[Cardiac disease in pregnancy and valvular heart disease#Tissue Prosthetic Valves|Tissue Prosthetic Valves]]===== |
|
| |
|
| # Increased first heart sound <br>
| | ===III. Cardiomyopathy=== |
| # Persistent split S2 <br>
| |
| # Third heart sound is uncommon <br>
| |
| # Pulmonic midsystolic murmur <br>
| |
| # Continuous murmur (mammary soufflé, cervical hum) <br>
| |
| # Varicosities and ankle edema <br>
| |
| # In general there are often innocent murmurs of pregnancy. These are the result of a hyperkinetic circulation. These murmurs are usually midsystolic and soft and heard best at the left lower sternal border and over the pulmonic area.<br> <br>
| |
|
| |
|
| == Laboratory Findings == | | =====[[Cardiac disease in pregnancy and dilated cardiomyopathy|Dilated Cardiomyopathy]]===== |
|
| |
|
| === Electrocardiogram === | | =====[[Cardiac disease in pregnancy and hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]===== |
|
| |
|
| *The QRS axis may shift either to the left or the right, but usually lies within normal limits.
| | =====[[Cardiac disease in pregnancy and peripartum cardiomyopathy|Peripartum Cardiomyopathy]]===== |
|
| |
|
| === Chest X Ray ===
| |
|
| |
|
| *The pelvic area should be shielded if a chest x-ray is done. The heart may seem enlarged due to elevation of the diaphragm and this should be interpreted with caution.
| | ===IV. Cardiac diseases that may develop During Pregnancy=== |
|
| |
|
| === MRI and CT === | | =====[[Cardiac disease in pregnancy and arrhythmias|Arrhythmias]]===== |
|
| |
|
| *'''MRI''': There are no known safety hazards but the experience with the technique is limited. Currently the FDA recommends prudence in using MRI during pregnancy.
| | =====[[Cardiac disease in pregnancy and myocardial infarction|Acute Myocardial Infarction]]===== |
|
| |
|
| === Echocardiography or Ultrasound === | | =====[[Cardiac disease in pregnancy and hypertension|Hypertension]]===== |
|
| |
|
| *'''Echo:''' There is a progressive increase in chamber dimension with approximately a 20% increase in the size of the right atrium and the right ventricle, a 12% increase in left atrial size, and a 6% increase in left ventricular size. Postpartum, the changes gradually returned to baseline. In addition, there is early and progressive dilation of the mitral, tricuspid, and pulmonary annuli which is associated with an increase in valvular regurgitation. | | ==External Links== |
| | *[http://eurheartj.oxfordjournals.org/content/early/2011/08/26/eurheartj.ehr218.full.pdf ESC Guidelines on the management of cardiovascular diseases during pregnancy] |
|
| |
|
| *'''Fetal Echo:''' <br>
| | {{WikiDoc Help Menu}} |
| # Risk factors for structural heart disease (i.e. who to ECHO):
| | {{WikiDoc Sources}} |
| #* women with a history of congenital heart disease themselves or in previous children <br>
| | [[CME Category::Cardiology]] |
| #* diabetes and collagen vascular disease predispose to congenital heart disease <br>
| |
| #* a history of a fetal arrhythmia <br>
| |
| #* consumption of teratogens <br> <br>
| |
| # Fetal ECHO <br>
| |
| #* one study found a sensitivity of 96% in detecting major structural malformations (72/74 abnormalities identified among 1,022 fetuses) <br>
| |
| #* useful for management during pregnancy, postpartum, and genetics counseling <br> <br>
| |
| | |
| === Other Diagnostic Studies ===
| |
| | |
| *'''Exercise stress testing:''' If this is done, there should be fetal monitoring.
| |
| | |
| *'''Radiation:''' If the patient receives less than five rads, then they can be reassured a very likelihood of risk. If they received more than 15 rads, termination of the pregnancy is recommended. Routine chest x-ray is associated with radiation of 20 millirads to the chest. Standard fluoroscopy delivers 1-2 rads per minute. Cineangiography delivers 5-10 rads per minute. Only 5% of the radiation delivered is absorbed by the fetus. A lead apron should be used over the mother's pelvis. With the use of nuclear medicine procedures the radiopharmaceuticals collect in the bladder when the placenta is directly across from the fetus. The expected radiation with thallium-201 or Tc imaging is less than one rad per examination.
| |
| | |
| *'''Pulmonary artery catheterization:''' Hemodynamic monitoring can be of great help in managing high-risk patients during pregnancy, labor, delivery, and the postpartum period. The pulmonary artery line should be placed without fluoroscopic guidance. Insertion is recommended throughout labor and delivery for any patient with symptomatic cardiac disease during pregnancy or with the potential for deterioration due to valvular, myocardial, or ischemic heart disease. Hemodynamic monitoring should be continued for at least several hours after delivery to ensure stability.
| |
| | |
| *'''Cardiac catheterization:''' May be indicated in rare instances of cardiac decompensation. To minimize radion to the pelvic and abdominal areas, the brachial, rather than the femoral approach is preferred.
| |
| | |
| == Pharmacotherapy ==
| |
| | |
| '''Antibiotic prophylaxis:''' <br>
| |
| The official [http://www.americanheart.org American Heart Association] (AHA) recommendation is that antibody prophylaxis is not necessary for an uncomplicated delivery except among patients with a prosthetic heart valve or surgically constructed systemic to pulmonary shunt. However, because of the difficulties in predicting complicated deliveries and the potential devastating consequences of endocarditis, antibiotic prophylaxis for vaginal delivery in all patients with congenital heart disease expect those with an isolated secundum type atrial septal defect and those six months or more after repair of septal defects or surgical ligation division of a patent duct is arteriosus, seems reasonable. At the time of delivery it is recommended that all women with valvular disease receive antibiotics, usually penicillin (PCN) and gentamycin. For those with a PCN allergy, vancomycin is used.
| |
| | |
| ==Specific Disease States==
| |
| | |
| ===[[Aortic Stenosis]]===
| |
| | |
| * Most commonly bicuspid valve
| |
| * Fixed C.O. in response to stress
| |
| * Patients with mild to moderate severity do very well
| |
| * Severe cases have maternal mortality up to 17% and fetal mortality up to 32%
| |
| * Critical cases need surgery/valvuloplasty
| |
| * Any reduction in preload can lead to cardiac/cerebral ischemia and compromised uterine flow
| |
| | |
| ===Congenital Heart Disease in Pregnancy===
| |
| | |
| ====Overview====
| |
| | |
| *Rapidly becoming most common cardiac problem among pregnant patients
| |
| **Improved diagnostic techniques
| |
| **Availability of corrective surgery
| |
| *Children of affected mothers at increased risk of having similar lesions
| |
| *Outcomes clearly linked to functional status pre-pregnancy
| |
| | |
| ====Classification of disease====
| |
| | |
| '''Can classify lesions into 3 classes:'''
| |
| | |
| =====Volume Overload (L-->R shunt) =====
| |
| | |
| *[[ASD]], [[VSD]], and [[PDA]] well tolerated if [[pulmonary hypertension]] not present
| |
| **PVR and SVR falls to same degree
| |
| **Degree of shunting does not change
| |
| *[[Eisenmenger’s Syndrome]]
| |
| **Maternal and fetal mortality ≥50%
| |
| :*Consider termination if detected early
| |
| :*Careful medical management
| |
| ::-Supplemental O2 during pregnancy
| |
| ::-Hospitalization at 20 weeks gestation
| |
| ::-Prompt treatment of [[CHF]]
| |
| ::-Avoid shifts in preload/afterload
| |
| | |
| =====Pressure Overload=====
| |
| | |
| *[[AS]], [[MS]]
| |
| *Pulmonic Stenosis
| |
| **Degree of obstruction determines outcome
| |
| **Gradient >80 mm Hg mandates correction
| |
| *[[Coarctation]] of the aorta
| |
| **Accounts for 9% of all congenital disease in adults
| |
| **Class I or II patients usually do well
| |
| **Overall 3.5% mortality in unoperated patients ([[aortic dissection]]/rupture, CVA, [[CHF]], [[endocarditis]])
| |
| **[[HTN]] needs careful management
| |
| *[[HOCM]]
| |
| **Early to mid pregnancy, C.O. and end-diastolic dimension ↓ outflow tract obstruction (counteracted by SVR)
| |
| ::*Avoid Valsalva
| |
| ::*Encourage left lateral decubitus position
| |
| **Maximum risk period during delivery when blood loss can result in increased gradient + systemic hypotension
| |
| ::*Keep well hydrated
| |
| ::*Avoid [[digoxin]], simpathomimetics and excessive diuretics
| |
| | |
| =====Cyanotic Heart Disease (R-->L shunt)<ref>Presbitero P. et al. Circulation 1994;89:2673-6.</ref>=====
| |
| | |
| *Poor prognosticators:
| |
| **Hematocrit > 60%
| |
| **O2 sat<85%
| |
| ::*Livebirth 12% vs. 92% is sat >90%
| |
| **Systemic RV pressures
| |
| **h/o recurrent [[syncope]]
| |
| *[[Tetralogy of Fallot]] most common unrepaired defect
| |
| **Drop in SVR leads to increased shunting, deeper [[cyanosis]] and rising HCT
| |
| **Need to avoid Valsava during delivery
| |
| **Maternal mortality more than 4%
| |
| | |
| ===[[Marfan's Syndrome]]===
| |
| * Autosomal dominant inheritance pattern (counseling is essential)
| |
| * Major risk is [[aortic dissection]]
| |
| :* Most common in 3rd trimester or 1st stage of labor
| |
| :* Increases with enlarging aortic root diameter
| |
| ::* Surgery recommended pre-conception if root diameter >40 mm
| |
| ::* Surgery recommend during gestation if > 55 mm
| |
| :* Prophylactic [[Beta-blockers]] appear to be helpful
| |
| * Close follow-up with serial echo
| |
| | |
| ===[[Mitral Stenosis]]===
| |
| | |
| '''Overview'''
| |
| | |
| * Most hemodynamically important valvular problem during pregnancy
| |
| * Physiologic changes result in increased pulse and C.O. with augmentation of diastolic gradient
| |
| * [[Atrial fibrillation]] can lead to rapid deterioration
| |
| * Volume shifts during delivery can result in [[pulmonary hypertension]] or [[pulmonary edema]]
| |
| | |
| '''Management of MS in Pregnancy'''
| |
| | |
| * Restriction of physical activity and salt intake. Avoid supine position
| |
| * [[Beta-blockade]] to lengthen disatolic filling period
| |
| * Diuretics if necessary (gentle)
| |
| * Consideration of invasive monitoring
| |
| * Replace blood losses during delivery carefully
| |
| * Percutaneous Balloon Mitral Valvuloplasty can be performed during pregnancy if necessary (Class III,IV)
| |
| | |
| ===[[Myocardial Infarction]]===
| |
| | |
| ====Overview====
| |
| | |
| * First reported case in 1922
| |
| * Incidence ~1/10000
| |
| * Ages range 16-45
| |
| * Most common in 3rd trimester women > 33 years of age
| |
| * Anterior wall most commonly involved
| |
| * Maternal mortality 21% (most at time of [[MI]] or within 2 weeks- usually with labor and delivery)
| |
| * Outcomes better if [[MI]] early in pregnancy
| |
| * Fetal deaths usually associated with maternal deaths
| |
| * Risk factors:
| |
| :* FH of CAD
| |
| :* [[Hyperlipidemia]]
| |
| :* Low HDL
| |
| :* High LDL
| |
| :* Smoking
| |
| :* Previous OCP use
| |
| | |
| ====Pathophysiology====
| |
| | |
| * Caths in 54% of published cases:
| |
| :* CAD with or without thrombus 43% (58% in prepartum period)
| |
| :* Thrombus without CAD 21%
| |
| :* Normal coronaries 29% (75% in peripartum period MIs)
| |
| :* Coronary dissection 16% (33% in postpartum period)
| |
| | |
| ====Diagnosis====
| |
| | |
| * EKG and enzymes are the gold standard
| |
| * 37% of patients undergoing elective C-section have EKG changes suggestive of [[MI]] or ischemia
| |
| * Echo to assess regional wall motion abnormalities can be useful
| |
| * Nuclear imaging and diagnostic cath exposure to conceptus <0.01 Gy (0.05 Gy considered to be threshold value)
| |
| | |
| ====Drugs====
| |
| | |
| Check with pharmacist or Maternal Fetal Medicine Specialist before any drug administration
| |
| | |
| * [[ASA]] - low dose
| |
| * Nitrates – use low dose to prevent fetal distress
| |
| * Beta-1 selective [[Beta-blockers]]
| |
| * [[Magnesium]]
| |
| * Morphine sulfate
| |
| * Avoid [[ACE inhibitors]] and [[warfarin]] due to teratogenicity
| |
| * Thrombolytics mostly untested
| |
| :* Greatest experience in massive [[pulmonary embolism]]
| |
| :* [[Streptokinase]] does not cross placental membrane in animals, but Ab found in neonatal spinal cord fluid
| |
| :* [[Urokinase]] not teratogenic in mice/rats
| |
| :* Risk for maternal hemorrhage (1 case of placental abruption reported); increased risk when given at time of delivery
| |
| :* Delivery best delayed at least 2-3 weeks
| |
| | |
| ===Peripartum Cardiomyopathy===
| |
| | |
| ====Diagnostic criteria (Demakis et al, 1971)====
| |
| | |
| * Development of CHF/LV dysfunction in last month of pregnancy to 5 months postpartum
| |
| :* Absence of determinable cause
| |
| :* Absence of demonstrable cardiac disease before last month of pregnancy
| |
| | |
| ====Common Mimickers====
| |
| | |
| * Accelerated HTN
| |
| * Infection/sepsis
| |
| * Diastolic dysfunction
| |
| * High output state of pregnancy
| |
| | |
| ====Demographics====
| |
| | |
| *Estimates of incidence 1/1300-15000
| |
| *Previous studies likely overestimated
| |
| *More common in women with:
| |
| :*Multiple pregnancies
| |
| :*African decent
| |
| :*h/o toxemia
| |
| :*Long-term tocolytic use
| |
| :*Age>30
| |
| :*Twin Pregnancy
| |
| * Etiology remains unknown
| |
| * Signs and sxs similar to those of nl pregnancy
| |
| | |
| ====Hemodynamic findings====
| |
| | |
| {| border="1" cellpadding="2" | |
| !width="100"|Chamber
| |
| !width="225"|Normal Pregnancy
| |
| !width="225"|Peripartum CMP
| |
| |-
| |
| |align="center"|RA ||align="center"|2 || align="center"|11 (2-34)
| |
| |-
| |
| |align="center"|PA ||align="center"|11 || align="center"|39 (18-62)
| |
| |-
| |
| |align="center"| PCW ||align="center"| 6 || align="center"|18 (5-32)
| |
| |-
| |
| |align="center"|CO (L/min) ||align="center"| 7 ||align="center"|6 (5-9)
| |
| |-
| |
| |align="center"|HR ||align="center"|83 ||align="center"|104 (76-142)
| |
| |}
| |
| | |
| ====Treatment of Peripartum CMP====
| |
| | |
| * [[Digoxin]] and diuretics are Class C
| |
| * [[ACE inhibitors]] absolutely contraindicated prepartum ([[hydralazine]] drug of choice)
| |
| * Anticoagulation recommended ([[Heparin]] prepartum and [[coumadin]] postpartum)
| |
| | |
| ====Outcome of Peripartum CMP====
| |
| | |
| * Mortality 25-50% (half deaths in first 3 months)
| |
| * Remainder stable/recover within 6 months
| |
| * Can recur with subsequent pregnancies
| |
| * Favorable outcomes with cardiac transplantation
| |
| | |
| ==='''Managing Prosthetic Valves During Pregnancy'''<ref>Vitale N., et al. JACC 1999;33:1637-41.</ref>===
| |
| | |
| * [[Pregnancy]] is a thrombogenic milieu
| |
| * [[Coumadin]] use during 1st trimester associated with warfarin embryopathy
| |
| * [[Coumadin]] use in other trimesters postulated to cause CNS abnormalities
| |
| * Keeping [[Coumadin]] dose ≤ 5.0 mg/day appears safe
| |
| * Recommendations based more on opinion than scientific evidence
| |
| * SBE Prophylaxis at Delivery
| |
| | |
| ===='''Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy'''<ref>Bates S.M. et al. Chest 2004;126:627S-44S.</ref>====
| |
| | |
| *In women with prosthetic heart valves, the guideline developers recommend:
| |
| | |
| #Adjusted-dose, twice-daily LMWH throughout pregnancy in doses adjusted either to keep a 4-hour postinjection anti-Xa heparin level at approximately 1.0 to 1.2 U/mL (preferable) or according to weight (Grade 1C), or
| |
| #Aggressive adjusted-dose [[UFH]] throughout pregnancy: i.e., administered SC every 12 hours in doses adjusted to keep the mid-interval a[[PTT]] at least twice control or to attain an anti-Xa heparin level of 0.35 to 0.70 U/mL (Grade 1C), or
| |
| #[[UFH]] or LMWH (as above) until the thirteenth week, change to warfarin until the middle of the third trimester, and then restart [[UFH]] or LMWH (Grade 1C).
| |
| ::''Remark:'' Long-term anticoagulants should be resumed postpartum with all regimens
| |
| #In women with prosthetic heart valves at high risk, the guideline developers suggest the addition of low-dose [[aspirin]], 75 to 162 mg/day (Grade 2C).
| |
| | |
| ===Regurgitant Valvular Lesions During Pregnancy===
| |
| | |
| * Usually tolerated very well during pregnancy
| |
| * Severity may decrease during pregnancy due to drop in SVR
| |
| * Vasodilators only if systemic HTN (avoid [[ACE-inhibitors]])
| |
| * Antibiotic prophylaxis important if infection suspected
| |
| | |
| ===Rheumatic Cardiac Disease in Pregnancy===
| |
| | |
| * Previously accounted for over 90% of CV disease during pregnancy
| |
| * Recent studies show congenital disease now more common
| |
| * Royal Infirmary at Edinburgh University: 94% (1928-47), 36% (68-77), 24% (73-77)
| |
| * Remains common in less developed nations
| |
| | |
| ===Pulmonary Hypertension in Pregnancy===
| |
| | |
| * High maternal / perinatal mortality (~50%)
| |
| * Vaginal delivery with limited anesthetics are preferred.
| |
| | |
| ==Resuscitation in Late Pregnancy==
| |
| | |
| Cardiac arrest occurs in approximately one in 30,000 women in late pregnancy.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref> Maternal mortality is caused by venous thromboembolism, severe preeclampsia or eclampsia, sepsis, amniotic fluid embolism, haemorrhage, trauma, iatrogenic causes including anaesthesia and drug errors or allergy, and congenital or acquired heart disease.<ref>Mallampalli A, Powner DJ, Gardner MO. Cardiopulmonary resuscitation and somatic support of the pregnant patient. Critical Care Clinics,. 2004;20:747-761.</ref>
| |
| | |
| Consideration of urgent hysterotomy or Caesarean section should be made for the pregnant woman who has a cardiac arrest. If early resuscitation fails, birth of the fetus may improve maternal and fetal chance of survival. Infants over 24-25 weeks gestation have the best chance of survival if birthed within 5 minutes of maternal cardiac arrest. It is recommended that hysterotomy or Caesarean section be commenced 4 minutes after a cardiac arrest unless there has been a successful resuscitation and maternal perfusion restored within that time.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| | |
| Obesity exaggerates the risks and physical changes in pregnant women.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| | |
| ===Position of the pregnant women===
| |
| | |
| * Position the women on her back with the shoulders flat. Place padding/wedge under the right buttock to give an obvious pelvic tilt to the left.<ref>Australian Resuscitation Council. Guideline 7 Cardiopulmonary resuscitation. In: Australian Resuscitation Council Guidelines; 2006.</ref>
| |
| * The thighs of a rescuer may be used for resting the women on, and providing a lateral tilt.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| * An assistant may move the uterus further off the vena cava by lifting the uterus with two hands to the left and towards the woman’s head.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| | |
| ===Airway management===
| |
| | |
| * The woman should be inclined laterally for suction, removing ill-fitting dentures or foreign bodies, and inserting airways.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| * Mouth to mouth or bag and mask ventilation is done with a pillow; the head and neck are fully extended.
| |
| * Apply cricoid pressure until the airway is protected by a cuffed tracheal tube if sufficient staff are available to do this – this decreases risk of gastric aspiration.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| * A soon as possible tracheal intubation should be inserted – ensures adequate ventilation with increased intra-abdominal pressure.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| * Consider using a smaller tracheal tube if the airway is narrowed due to oedema and swellling.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| * Positioning for intubation - using one pillow helps to flex the neck and extend the head.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| | |
| ===Circulation management===
| |
| | |
| * Adhesive defibrillator pads attachment are used to assist contact which may be difficult due to the larger breasts in the pregnant woman.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| * Hand position higher than the normal position for chest compressions may be needed to adjust for the elevation of the diaphragm and abdominal contents due to the gravid uterus.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| * Raising the woman’s legs will assist venous return.<ref name="Morris"> Morris S, Stacey M. Resuscitation in pregnancy. BJM 2003;327:1277-1279.</ref>
| |
| | |
| ===Gastrointestinal management===
| |
| | |
| Early intubation decreases the risk of gastric aspiration.<ref name="Soar"> Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;6751:S135-S170.</ref>
| |
| | |
| ===Intiating caesarean section===
| |
| | |
| Immediately a pregnant woman collapses and requires resuscitation a staff member should collect the Caesarean Section Perimortem pack.
| |
| | |
| ==References==
| |
| {{Reflist|2}} | |
| | |
| ==Sources:==
| |
| | |
| * [http://www.kemh.health.wa.gov.au/development/manuals/O&G_guidelines/sectionb/11/5334.pdf Australian Government Health Pages]
| |
| | |
| == Acknowledgements ==
| |
| The content on this page was first contributed by [[C. Michael Gibson]] M.S., M.D.
| |
| | |
| {{Circulatory system pathology}}
| |
| {{Electrocardiography}}
| |
| {{SIB}}
| |
|
| |
|
| | [[Category:Disease]] |
| | [[Category:Cardiology]] |
| [[Category:Electrophysiology]] | | [[Category:Electrophysiology]] |
| [[Category:DiseaseState]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Emergency medicine]] | | [[Category:Emergency medicine]] |
| | | [[Category:Obstetrics]] |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |